Midlife Migraine/Aura Linked With Late-Life Brain Infarcts

2007 ◽  
Vol 40 (23) ◽  
pp. 13
Author(s):  
DENISE NAPOLI
JAMA ◽  
2009 ◽  
Vol 301 (24) ◽  
pp. 2563 ◽  
Author(s):  
Ann I. Scher

Neurology ◽  
2018 ◽  
Vol 91 (6) ◽  
pp. e517-e525 ◽  
Author(s):  
Zoe Arvanitakis ◽  
Ana W. Capuano ◽  
Melissa Lamar ◽  
Raj C. Shah ◽  
Lisa L. Barnes ◽  
...  

ObjectiveTo examine associations of average and change in late-life blood pressure (BP) with cerebrovascular and Alzheimer disease (AD) neuropathology in a large group of decedents followed longitudinally in vivo.MethodsThis clinical-pathologic study was derived from prospective, community-based cohort studies of aging with similar design and data collection. Measurements of systolic BP (SBP) and diastolic BP (DBP) were obtained annually (mean follow-up 8 years, SD = 4.8). Postmortem neuropathologic evaluations documented diseases of aging. Using regression analyses, we examined associations of average and decline in late-life SBP, and separately in DBP, with neuropathology.ResultsIn 1,288 persons (mean age at death = 88.6 years; 65% women), the mean standardized person-specific SBP across the study was 134 (SD = 13) and DBP was 71 (SD = 8) mm Hg. The odds of brain infarcts were increased for participants with a higher mean SBP. Specifically, a person with a 1 SD SBP above the mean (147 vs 134 mm Hg) would have a 46% increased odds of having one or more infarcts, and an increased odds of gross infarct (46%) and microinfarct (36%). Furthermore, a more rapidly declining SBP slope over time increased the odds of one or more infarcts. Mean DBP, not slope, was related to brain infarcts. AD pathology analyses showed an association of a higher mean SBP with higher number of tangles (p = 0.038) but not plaques or other pathology (all p > 0.06). Changes in BP were not significantly related to AD pathology.ConclusionsHigher average late-life SBP and DBP, and independently a faster decline in SBP, are associated with increasing number of brain infarcts, including gross and microinfarcts. We found some evidence for a relation of SBP with AD, specifically tangles. Both average and decline in BP are related to brain disease.


2009 ◽  
Vol 64 (11) ◽  
pp. 734-735
Author(s):  
Ann I. Scher ◽  
Larus S. Gudmundsson ◽  
Sigurdur Sigurdsson ◽  
Anna Ghambaryan ◽  
Thor Aspelund ◽  
...  

Hypertension ◽  
2020 ◽  
Vol 76 (3) ◽  
pp. 707-714
Author(s):  
Rodica Elena Petrea ◽  
Adrienne O’Donnell ◽  
Alexa S. Beiser ◽  
Mohammad Habes ◽  
Hugo Aparicio ◽  
...  

The duration and lifetime pattern of hypertension is related to risk of stroke and dementia. In turn, cerebral small vessel disease (CSVD) is the most frequent form of cerebrovascular disease underlying dementia and stroke. Thus, study of the relation of mid to late life hypertension trends with CSVD late in life will help understand hypertension’s role and inform preventive efforts of CSVD consequences. We studied 1686 Framingham Heart Study Offspring cohort participants free of stroke and dementia, who were examined in mid and late life, and had available brain magnetic resonance imaging during late life. We related hypertension trends between mid and late life (normotension–normotension N-N, normotension-hypertension N-H, hypertension-hypertension H-H) to cerebral microbleeds and covert brain infarcts (CBI), overall and stratified by brain topography. We used multivariable logistic regression analyses to calculate odds ratio and 95% CIs for CSVD measures. The prevalence of CSVD in late life was 8% for cerebral microbleeds and 13% for covert brain infarcts and increased with longer hypertension exposure across all brain regions. Compared with the trend pattern of N-N, both N-H and H-H trends had higher odds of mixed cerebral microbleeds (2.71 [1.08–6.80], and 3.44 [1.39–8.60], respectively); H-H also had higher odds of any cerebral microbleeds or covert brain infarcts (1.54 [1.12–2.20]), and any covert brain infarcts (1.55 [1.08–2.20]). The burden of CSVD also increased with longer hypertension exposure. Our results highlight hypertension having a major role in subclinical CSVD, across subtypes and brain regions, and call attention to improve recognition and treatment of hypertension early in life.


2011 ◽  
Vol 44 (6) ◽  
pp. 29
Author(s):  
MICHELE G. SULLIVAN
Keyword(s):  

GeroPsych ◽  
2015 ◽  
Vol 28 (2) ◽  
pp. 67-76
Author(s):  
Grace C. Niu ◽  
Patricia A. Arean

The recent increase in the aging population, specifically in the United States, has raised concerns regarding treatment for mental illness among older adults. Late-life depression (LLD) is a complex condition that has become widespread among the aging population. Despite the availability of behavioral interventions and psychotherapies, few depressed older adults actually receive treatment. In this paper we review the research on refining treatments for LLD. We first identify evidence-based treatments (EBTs) for LLD and the problems associated with efficacy and dissemination, then review approaches to conceptualizing mental illness, specifically concepts related to brain plasticity and the Research Domain Criteria (RDoc). Finally, we introduce ENGAGE as a streamlined treatment for LLD and discuss implications for future research.


2001 ◽  
Vol 69 (2) ◽  
pp. 227-239 ◽  
Author(s):  
Kenneth L. Lichstein ◽  
Brant W. Riedel ◽  
Nancy M. Wilson ◽  
Kristin W. Lester ◽  
R. Neal Aguillard
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document